Join the club.

The game is rigged.

Insiders profit every day on information you don't have. Legally. We pull back the curtain. Built for the curious — the ones who refuse to accept the surface story.

Sign up

Live data, not a marketing demo

What insiders did this week.

Every row is a real SEC filing. Tap anything to see the full story — that part's behind a subscription.

Corporate insiders

Latest big buys

See all corporate trades
Congress trades

Senators & Reps

Browse all Congress trades
Market news

Daily briefs

Read more news

We are not OpenInsider

Want raw filings? Go to SEC EDGAR or OpenInsider. They're free.

Want to know which filings actually predict price moves? That's what we do.

Our AI watches every filing and tells you which ones matter, based on 16,000+ past trades we've analyzed.

Recent wins

Three trades that worked.

Every one of these was filed publicly. Every one was ignored by almost everyone.

$TRAWTraws Pharma, Inc.
Orbimed Advisors LLC · 10% · bought April 28, 2026
+91.2%
10 days
$TRAW · daily closepost-filing window

On April 28, 2026, Orbimed Advisors LLC, a major shareholder in Traws Pharma, bought more shares. 10 days later, the stock was up 91%.

Kilts James M
$ADVAdvantage Solutions Inc.
Kilts James M · Dir · bought March 24, 2026
+62.9%
30 days
$ADV · daily closepost-filing window

On March 24, 2026, Kilts James M, a director at Advantage Solutions, bought stock in their own company. 30 days later, the stock was up 63%.

Bertolini Mark T
$OSCROscar Health, Inc.
Bertolini Mark T · CEO · bought April 7, 2026
+45.6%
30 days
$OSCR · daily closepost-filing window

On April 7, 2026, Bertolini Mark T, the CEO at Oscar Health, bought stock in their own company. 30 days later, the stock was up 46%.

Pick a plan

Get a piece of the action.

Two tiers. Cancel any time. Sign up takes about 60 seconds.

Plus
For the curious investor
$15.83/month
$190 billed yearly
  • Full access to every insider trade
  • Filter, search, and watchlists
  • Plain-English AI analysis on every trade
  • Daily market news, fully unlocked
  • Track up to 20 stocks
Recommended
Pro
For the serious trader
$165.83/month
$1,990 billed yearly
  • Everything in Plus
  • Real-time automated alerts on validated patterns
  • Higher AI usage limits
  • Track unlimited stocks
  • API access + paper-trading bot integration

Common questions.

Where does the data come from?

Corporate insider trades come directly from SEC Form 4 filings. Congress trades come from STOCK Act disclosures. All of it is public — we just monitor it, score it, and tell you which ones matter.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Insider trading on private information is what's illegal — that's a different thing.

What's the difference between you and OpenInsider?

OpenInsider gives you raw filing data — every Form 4 in the order it landed. We've analyzed 16,000+ past trades to find which patterns actually predicted price moves, and we surface the ones that match those patterns in real time.

Can I cancel?

Any time, from your account page. No phone call. No retention chat. You keep access until the end of the billing period you already paid for.

What we show is real and public. What you do with it is your call. Not financial advice.